Sign inJoin waitlistJoin the waitlist

Christopher Dandoy

Associate Professor of Clinical-Affiliate · University of Cincinnati Medical Center Inc.

Credentials: · · · · · ·

History

University of Cincinnati Medical Center Inc.
Present
Cincinnati Children's Hospital Medical Center
Present

Pediatric Hematology-Oncology
Cincinnati Children's Hospital Medical Center
2013–2014
Pediatrics
Nicklaus Children's Hospital
2007–2010
University of Utah School of Medicine
2003–2007
Weber State University
1999–2003

Research

Diagnostic and risk criteria for HSCT-associated thrombotic microangiopathy: a study in children and young adults
Blood · 2014 · 346 citations
Clinical characteristics and outcomes of COVID-19 in haematopoietic stem-cell transplantation recipients: an observational cohort study
The Lancet Haematology · 2021 · 305 citations
A new paradigm: Diagnosis and management of HSCT-associated thrombotic microangiopathy as multi-system endothelial injury
Review · Blood Reviews · 2015 · 267 citations

Stella Davies
79 papers
Sonata Jodele
68 papers
Kasiani Myers
44 papers
JE
Javier El-Bietar
30 papers
Seth Rotz
24 papers · 9 as a fellow
Hillard Lazarus
19 papers
Jeffery Auletta
19 papers
GW
Gregory Wallace
18 papers
BS
Bipin Savani
17 papers
Leslie Lehmann
16 papers
MR
Marcie Riches
16 papers
MP
Miguel-Angel Perales
16 papers

Grants

Reduction of Bloodstream Infections from Oral Organisms in Pediatric Stem Cell Transplant: A Randomized Multicenter Double-Blind Placebo-Controlled Study Evaluating Twice Daily Oral Xylitol
National Institute of Dental and Craniofacial Research · UH3
Contact PI · $2.1M · Cincinnati Childrens Hosp Med Ctr
2022–2027
The 11th Annual PTCTC Educational Meeting, The First 100 Days After Stem Cell Transplant
National Heart, Lung, and Blood Institute · R13
Contact PI · $22K · Cincinnati Childrens Hosp Med Ctr
2024–2025
Reduction of Bloodstream Infections from Oral Organisms in Pediatric Stem Cell Transplant: A Randomized, Multicenter, Double-Blind, Placebo-Controlled Study Evaluating Twice Daily Oral Xylitol
National Institute of Dental and Craniofacial Research · UG3
Contact PI · $490.2K · Cincinnati Childrens Hosp Med Ctr
2021–2022
Automated Activities of Daily Living (ADL) Adherence System to Reduce Complications After Intensive Cancer Therapy in Pediatrics
National Cancer Institute · R21
Contact PI · $375.2K · Cincinnati Childrens Hosp Med Ctr
2018–2021

Clinical trials

Haploidentical Donor Cytokine-Induced Memory-Like Natural Killer Cells (CIML-NK) for Relapsed & Refractory Neuroblastoma
Principal investigator · Recruiting · Phase 2
Children's Hospital Medical Center, Cincinnati
2026–2031
Xylitol BSI Multisite - Reduction of Bloodstream Infections From Oral Organisms in Pediatric Stem Cell Transplant
Principal investigator · Active not recruiting · Phase 2
Children's Hospital Medical Center, Cincinnati
2023–2026
Time Restricted Nutrition in Pediatric Stem Cell Transplant Recipients
Principal investigator · Completed
Children's Hospital Medical Center, Cincinnati
2020–2022